Neuberger Berman Group
BMRN icon

Neuberger Berman Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.75M Sell
31,757
-64,410
-67% -$3.54M ﹤0.01% 1189
2025
Q1
$6.8M Buy
96,167
+2,415
+3% +$171K 0.01% 866
2024
Q4
$6.16M Sell
93,752
-803,827
-90% -$52.8M ﹤0.01% 910
2024
Q3
$63.1M Sell
897,579
-196,614
-18% -$13.8M 0.05% 398
2024
Q2
$90.1M Buy
1,094,193
+628,463
+135% +$51.7M 0.07% 298
2024
Q1
$40.7M Buy
465,730
+117,008
+34% +$10.2M 0.03% 495
2023
Q4
$33.6M Buy
348,722
+108,094
+45% +$10.4M 0.03% 499
2023
Q3
$21.3M Buy
240,628
+40,032
+20% +$3.54M 0.02% 592
2023
Q2
$17.4M Buy
200,596
+46,549
+30% +$4.03M 0.02% 636
2023
Q1
$15M Sell
154,047
-14,975
-9% -$1.46M 0.01% 671
2022
Q4
$17.5M Buy
169,022
+2,185
+1% +$226K 0.02% 647
2022
Q3
$14.1M Buy
166,837
+139,356
+507% +$11.8M 0.01% 662
2022
Q2
$2.28M Sell
27,481
-242
-0.9% -$20.1K ﹤0.01% 1079
2022
Q1
$2.14M Sell
27,723
-4,964
-15% -$383K ﹤0.01% 1159
2021
Q4
$2.68M Buy
32,687
+5,442
+20% +$446K ﹤0.01% 1123
2021
Q3
$1.96M Sell
27,245
-5,386
-17% -$387K ﹤0.01% 1172
2021
Q2
$2.58M Sell
32,631
-4,570
-12% -$361K ﹤0.01% 1113
2021
Q1
$2.74M Buy
37,201
+1,391
+4% +$102K ﹤0.01% 1081
2020
Q4
$3.12M Sell
35,810
-42,171
-54% -$3.67M ﹤0.01% 1023
2020
Q3
$5.93M Sell
77,981
-7,344
-9% -$559K 0.01% 822
2020
Q2
$10.5M Sell
85,325
-118,187
-58% -$14.6M 0.01% 705
2020
Q1
$17.2M Sell
203,512
-3,419
-2% -$289K 0.03% 528
2019
Q4
$17.5M Buy
206,931
+26,156
+14% +$2.21M 0.02% 624
2019
Q3
$12.2M Sell
180,775
-735,538
-80% -$49.6M 0.01% 681
2019
Q2
$78.5M Sell
916,313
-138,025
-13% -$11.8M 0.09% 302
2019
Q1
$93.7M Sell
1,054,338
-214,426
-17% -$19M 0.11% 262
2018
Q4
$108M Sell
1,268,764
-35,754
-3% -$3.04M 0.15% 214
2018
Q3
$126M Buy
1,304,518
+116,452
+10% +$11.3M 0.14% 212
2018
Q2
$112M Buy
1,188,066
+471,829
+66% +$44.4M 0.12% 240
2018
Q1
$58.1M Buy
716,237
+411,140
+135% +$33.3M 0.07% 374
2017
Q4
$27.2M Buy
305,097
+181,192
+146% +$16.2M 0.03% 562
2017
Q3
$11.5M Sell
123,905
-117,050
-49% -$10.9M 0.01% 723
2017
Q2
$21.9M Buy
240,955
+79,759
+49% +$7.24M 0.03% 583
2017
Q1
$14.2M Buy
161,196
+2,298
+1% +$202K 0.02% 676
2016
Q4
$13.2M Sell
158,898
-142,445
-47% -$11.8M 0.02% 690
2016
Q3
$27.9M Buy
301,343
+684
+0.2% +$63.3K 0.04% 506
2016
Q2
$23.4M Buy
300,659
+140,055
+87% +$10.9M 0.03% 543
2016
Q1
$13.2M Sell
160,604
-25,162
-14% -$2.08M 0.02% 699
2015
Q4
$19.5M Sell
185,766
-55,089
-23% -$5.77M 0.03% 609
2015
Q3
$25.4M Buy
240,855
+577
+0.2% +$60.8K 0.03% 569
2015
Q2
$32.9M Sell
240,278
-33,185
-12% -$4.54M 0.04% 537
2015
Q1
$34.1M Sell
273,463
-144,824
-35% -$18M 0.04% 527
2014
Q4
$37.8M Sell
418,287
-115,990
-22% -$10.5M 0.04% 486
2014
Q3
$38.6M Sell
534,277
-707,027
-57% -$51M 0.04% 494
2014
Q2
$77.2M Sell
1,241,304
-436,696
-26% -$27.2M 0.08% 353
2014
Q1
$114M Buy
1,678,000
+425,778
+34% +$29M 0.12% 267
2013
Q4
$88.1M Buy
1,252,222
+620,400
+98% +$43.6M 0.09% 328
2013
Q3
$45.6M Buy
631,822
+368,287
+140% +$26.6M 0.05% 426
2013
Q2
$14.7M Buy
+263,535
New +$14.7M 0.02% 674